From #EuroPCR2025 🔥🔥🔥
A prospective study evaluating next-day and 48-hour discharge after alternative access TAVI (subclavian/axillary, carotid, transapical) found no increase in 30-day readmission or mortality across discharge strategies.
Read more here: ow.ly/Cme050VWWOg
#EAPCI #earlydischarge